Target intelligence / Profile preview

Ribosomal protein L35a pseudogene 9 (RPL35AP9)

Target: RPL35AP9
Molecular classification: Other (Pseudogene)[3][4]

Overview

Ribosomal protein L35a pseudogene 9 is a human pseudogene derived from the RPL35A gene, which encodes a component of the large ribosomal subunit. The RPL35AP9 gene does not produce a functional protein and is not expressed in a manner that imparts biological or therapeutic relevance. It is cataloged as a pseudogene primarily for genomic annotation purposes and has no recognized role in disease, drug targeting, or clinical diagnostics[3][4][6].

Other names: RPL35A_2_427[4][6]NCBI Gene: 100271311[3][4][6]

Biological functions

Other (no protein-coding function; does not have known biological activity)[3][4]

Disease associations

Other (no known disease association; not implicated in any pathology)[3][4]

Beyond the preview

Go deeper on Ribosomal protein L35a pseudogene 9 (RPL35AP9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L35a pseudogene 9 (RPL35AP9).

Explore the full profile